Financial Statements — SOLS
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 |
|---|
| Cash & Equivalents | 0.75 | 0.64 | 0.42 |
| Accounts Receivable | 0.67 | 0.63 | 0.64 |
| Inventory | 0.67 | 0.70 | 0.73 |
| Total Current Assets | 2.57 | 2.44 | 1.88 |
| Property, Plant & Equipment | 2.13 | 2.08 | 1.95 |
| Goodwill | 0.82 | 0.82 | 0.82 |
| Intangible Assets | 0.02 | 0.02 | 0.01 |
| Total Non-current Assets* | 3.35 | 3.31 | 3.37 |
| Total Assets | 5.92 | 5.75 | 5.25 |
| Accounts Payable | 0.94 | 0.91 | 0.87 |
| Total Current Liabilities | 1.76 | 1.71 | 1.23 |
| Long-term Debt | 2.06 | 2.07 | -- |
| Total Non-current Liabilities* | 2.57 | 2.57 | 0.84 |
| Total Liabilities | 4.33 | 4.28 | 2.07 |
| Retained Earnings | 0.22 | 0.11 | -- |
| Total Stockholder Equity | 1.59 | 1.49 | 3.23 |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Total Revenue | 1.15 | 0.99 | 0.99 | 0.97 |
| Cost of Revenue | 0.78 | 0.68 | 0.73 | 0.66 |
| Gross Profit | 0.37 | 0.32 | 0.26 | 0.31 |
| Research & Development | 0.03 | 0.03 | 0.03 | 0.03 |
| Selling, General & Admin | 0.12 | 0.11 | 0.11 | 0.11 |
| Pretax Income | 0.18 | 0.14 | 0.09 | 0.17 |
| Tax Provision | 0.04 | 0.03 | 0.03 | 0.18 |
| Net Income | 0.12 | 0.09 | 0.04 | (0.04) |
| Basic EPS | 0.75 | 0.53 | -- | -- |
| Diluted EPS | 0.75 | 0.53 | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 |
|---|
| Operating Cash Flow | 262.00 | 199.00 | 166.00 | 289.00 |
| Capital Expenditures | 138.00 | 75.00 | 88.00 | 248.00 |
| Free Cash Flow* | 124.00 | 124.00 | 78.00 | 41.00 |
| Investing Cash Flow | (138.00) | (77.00) | (102.00) | (228.00) |
| Financing Cash Flow | (16.00) | (15.00) | 93.00 | (328.00) |
* Derived from reported values
Dividends Per Share
(USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Dividends Per Share | 0.08 | 0.08 |
